Objectives: To examine the relative roles of eNOS and iNOS (endothelial and inducible nitric oxide synthases) on basal and b-adrenergic receptor (b-AR)-stimulated arterial hemodynamic responses after myocardial infarction (MI). Methods: Left ventricular (LV) pressures and steady-state and pulsatile arterial hemodynamics were measured at baseline, and after acute NOS inhibition with either G N -nitro-L-arginine methyl ester (L-NAME, 100 mg / kg) or iNOS inhibition with aminoguanidine (AG, 75 mg / kg) in sham-operated and MI Sprague-Dawley rats. Results: In sham rats, L-NAME decreased (P,0.05) peak positive LV dP/dt and aortic blood velocity by 19% and 53%, respectively, and increased (P,0.05) mean arterial pressure (MAP), systemic vascular resistance, and LV end-diastolic pressure (EDP) by 20, 189 and 89%, respectively. The frequency-dependent components of hemodynamics including aortic input impedance modulus, characteristic impedance, and phase shift were increased (P,0.05) with L-NAME, while pulsatile power was decreased (P,0.05). AG increased (P,0.05) aortic input impedance modulus and characteristic impedance but had no effect on any other hemodynamic variable. In MI rats, L-NAME decreased (P,0.05) LV dP/dt and aortic blood velocity by 22 and 55%, respectively, and increased (P,0.05) SVR by 108%. There was no effect of L-NAME on MAP or LV EDP in MI rats. After MI, AG increased (P,0.05) heart rate and LV dP/dt but had no effect on other LV or pulsatile hemodynamic variables. Compared to sham rats, heart rate, LV dP/dt, and blood velocity-isoproterenol dose responses were shifted downward (P,0.05), while SVR-isoproterenol dose response was shifted 22 upward (P,0.05) in MI rats. In sham rats, L-NAME potentiated (P,0.05, at .10 mg / kg) the isoproterenol-induced increase in LV dP/dt and aortic blood velocity, and potentiated (P,0.05) the isoproterenol-induced decline in SVR. As expected, AG had no effects on isoproterenol-stimulated hemodynamics in sham rats. After MI, there was no effect of L-NAME or AG on isoproterenol-stimulated hemodynamics. Conclusions: (1) Circulatory and cardiac responses to inhibition of NO by L-NAME suggest that eNOS, but not iNOS, is the principal regulator of integrated arterial hemodynamic function in rats. (2) Both basal and b-AR-stimulated NO regulation of hemodynamic are attenuated after MI. (3) The attenuation of arterial hemodynamic effects after isoproterenol is mediated, in part, by alterations in the b-AR-activation of eNOS system after MI.
Introduction
arterial vasodilatory response to b-adrenergic receptor (b-AR) stimulation are attenuated in heart failure [2] [3] [4] . Since In heart failure, inappropriate vasoconstriction results there is a cross-talk between the b-AR and the NO from impaired endothelial-dependent vasodilatation. Alpathways, one potential mechanism that may contribute to though activation of a number of neurohumoral systems b-AR hypo-responsiveness is altered vascular endothelial play a role in this inappropriate vasoconstriction, alterafunction. tions in endothelial nitric oxide (NO) release and diIn the cardiovascular system, NO is produced by two minished vascular b-AR function [1] are important. Vascuisoforms of nitric oxide synthase (NOS), eNOS and iNOS lar endothelial release of NO, a potent vasodilator, and the [5, 6] . The eNOS species is constitutively expressed and can be stimulated with interventions that increase cytosolic 21 Ca . In contrast, iNOS is a cytokine-inducible isoenzyme [6] . Heart failure is characterized by elevated eNOS and thoracotomy but did not have the coronary artery ligated iNOS activity in cardiac muscle, while NO basal release in were designated as sham-operated controls. Studies were large arteries is diminished [2] [3] [4] . The eNOS isoform has performed 6 weeks post-infarction in sham and MI rats. been shown to play a major role in circulatory function in hypertension, but there are limited data in heart failure 2.2. Hemodynamic measurements [7, 8] . The iNOS isoform may have an important effect on hemodynamics early after myocardial infarction (MI) [9] , In vivo hemodynamics were measured using methods when inflammatory cytokine levels are elevated, but the previously reported by our laboratory [10] . In brief, rats effects of iNOS in compensated ischemic heart failure are were anesthetized with Inactin (100 mg / kg) and the unknown. Although ischemic heart failure is characterized trachea ventilated. A 2 F micromanometer catheter with by increased vascular resistance, alterations in pulsatile two pressure sensors (Millar) was inserted via the right hemodynamics [10] , and impairment of endothelial funcfemoral artery such that one sensor was located in the left tion, the role of NO on in vivo circulatory function that ventricle and the other in the ascending aorta. The zero includes steady-state and pulsatile hemodynamics has not pressure baseline was obtained by placing the pressure been examined. sensor in 378C saline prior to measurements. A 3 F The objectives of the current study, therefore, are to (1) echo-Doppler catheter (Millar Instruments) introduced via define the effects of NOS inhibition on complete arterial the right carotid artery was used to measure the aortic hemodynamics in ischemic heart failure, and to (2) define blood velocity. After a period of stabilization, LV and the effects of NOS inhibition on b-AR responsiveness. The aortic pressures and aortic blood velocity were recorded underlying hypothesis is that NOSs play a major role in and digitized at a rate of 1000 Hz using a PC equipped controlling circulatory function in heart failure. We also with an analog-digital converter and customized software. postulate that the effects of basal and b-AR stimulation on From these data, LV dP/dt and the time constant of LV NO release are diminished in heart failure. This study is relaxation (t) were calculated. A systemic vascular resistperformed in rats with compensated heart failure, 6 weeks ance (SVR) index was calculated as the quotient between after coronary artery ligation [11, 12] . mean arterial pressure (MAP) and blood velocity. The aortic pressures and flow waves were decomposed into harmonics using Fourier analysis. modules at zero frequency. The mean power was calculated by multiplying the mean pressure by the mean flow.
Myocardial infarction model
Pulsatile power was calculated using the following equa-2 tion; W 50.5 S(Q ) Z cos w , where is the harmonic p n n n MI was created using techniques standard in our laboranumber, Q is the amplitude of the nth flow harmonic, Z n n tory [10, 11] . In brief, 3-month old Sprague-Dawley rats is the amplitude of the nth impedance, and w is the phase n weighing 250-300 g were anesthetized with ketamine and angle of the nth harmonics. acepromazine and a left thoracotomy was performed. The After obtaining the hemodynamic measurements, a heart was expressed from the thorax and a ligature placed midsternal thoractomy was performed and the ascending around the proximal left coronary artery. The heart was aorta was isolated to measure the aortic diameter. By returned to the chest and the thorax closed. The rats were hemorrhage or intravenous fluid infusion, the MAP was maintained on standard rat chow and water ad libitum.
adjusted to the same pressure as that during acquisition of After 3 weeks, rats were anesthetized with methoxthe impedance data. Then the aortic diameter was meayflourane and a nine lead ECG performed. With criteria sured optically using a telemicroscope (M101, Gaenther described previously [13] , rats with evidence of large MI Scientific, IL, USA). At the end of the experiment, the were selected for study. Briefly, the presence of Q waves heart was arrested by KCl injection (2 mEquiv. / ml) into (.1 mV) in the limb leads (I or aVL) and the sum of the R the left ventricle, excised, rinsed, visually examined for waves in the precordial leads (,10 mV) were used as infarct size, and the left and right ventricle separated and criteria for large MI. Our laboratory has shown that rats weighed. selected in this fashion have large MI averaging 40% of the left ventricle [13] . MI was confirmed 3 weeks later by 2.3. Effects of NOS inhibition on hemodynamics hemodynamics (LV end-diastolic pressure (EDP) .16 mmHg) and presence of large scar. Only rats with eviTo determine the appropriate NOS inhibiting dose of dence of a large MI were used. Animals that underwent L-NAME and AG, pilot studies were performed in four Table 1 separate groups of rats (20 rats) to measure the hemo- For the remainder of the study, a total of 68 rats were divided into two groups: (1) sham, (2) MI. In order to determine the role of the basal release of NO on in vivo no change in MAP, a 40% decrease (P,0.01) in aortic hemodynamics, measurements were made before and 20 blood velocity, with no change in heart rate (HR). The min after the i.v. administration of either L-NAME (100 other hemodynamic changes after infarction were a fourmg / kg) or AG (75 mg / kg) in sham and MI rats. The role fold increase (P,0.01) in LV end diastolic pressure, a of NO inhibition on b-AR hemodynamic response was doubling (P,0.01) of SVR, and a 48% increase (P,0.01) determined from the dose-response data to isoproterenol in the time constant of LV relaxation constant or t (Fig. 1 ).
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(10 -2 mg / kg) before and 20 min after the intravenous MI was associated with an increase (P,0.05) in the administration of either L-NAME (100 mg / kg) or AG (75 characteristic impedance and decrease (P,0.05) in stroke mg / kg). Measurements after L-NAME and AG were volume and LV power ( Table 2 ). These baseline measureperformed in separate groups of rats.
ments are consistent with previous data from our laboratory and others using the rat coronary artery ligation model 2.4. Statistical analysis of heart failure [10, 11] .
All results are expressed as mean6S.D. Statistical 3.3. L-NAME and AG dose-dependent changes in comparisons after the addition of L-NAME and AG were hemodynamics carried out using two-way analysis of variance (ANOVA). To examine the interaction between MI and NOS inhibiIn sham rats, L-NAME increased MAP in a dose-depention, a 232 matrix was employed in which sham / MI dent manner (1-1000 mg / kg), but the animals could not (yes / no) represents one dimension and L-NAME or AG tolerate doses higher than 100 mg / kg of L-NAME. Thereadministration (yes / no) the other. For both sham and MI fore, a dose of 100 mg / kg, which achieved a maximal rats, additional two 232 matrices were employed to increase in arterial pressure without distorting the rest of examine the interaction between NOS inhibition and bthe hemodynamic variables, was chosen in the remainder AR-mediated responses in which isoproterenol treatment of the study. In contrast, AG did not effect the hemo-(yes / no) represents one dimension and L-NAME or AG dynamics at any dose studied (10-80 mg / kg). Doses of administration (yes / no) the other. Following the two-way AG .80 mg / kg increased MAP due to nonspecific ANOVA, intergroup comparisons using the Newmaninhibition of eNOS [25] . Therefore, a dose of 75 mg / kg Keuls procedure were performed. Analysis was performed AG was chosen in the remainder studies to insure complete using BMDP statistical software. Level of significance was inhibition of the iNOS enzyme. taken at P,0.05.
Effects of L-NAME and AG on baseline

Results hemodynamics
Animal characteristics
The administration of L-NAME resulted in the following changes: decreases (P,0.01) in LV dP/dt of 19% in sham In rats after MI, body weight and LV weight decreased rats and 22% in MI rats, a 20% increase (P50.01) in MAP (P50.005, 0.001, respectively) while right ventricular in sham rats and no change in MI rats, decreases (P,0.01) weight and LV EDP increased (P50.001, Table 1 ). The of 53% in blood velocity in sham rats compared to 55% in elevation in both right ventricular weight and LVEDP MI rats, increases (P,0. rats and 18% in MI rats), and increases (P#0.01) 105% in t in sham rats compared to a 52% in MI rats (Fig. 1) . AG MI resulted in a 34% decrease (P,0.01) in LV dP/ dt, (75 mg / kg) had no effect on any hemodynamic variable except it increased (P#0.01) both HR (13%) and LV dP/ dt 3.6. Effects of b-AR-stimulated NO on steady (29%) in rats after MI only (Fig. 1) .
circulatory response in intact animals
Effects of MI on b-AR-mediated circulatory The cumulative isoproterenol dose-response data after response in intact animals
L-NAME are presented as the change with each data set (sham and MI) normalized for their respective baselines, The cumulative isoproterenol dose-response data are i.e., subtracting the baseline response to L-NAME such that presented as the change with each data set (sham and MI) the change represents differences from the sham data ( Fig.  normalized for their respective baselines, i.e., subtracting 2). This was done in order to define the effects of NOS the baseline response in MI from sham (Fig. 2) . In rats inhibition on isoproterenol induced responses independent after MI, isoproterenol dose-response curves for LV dP/ dt of baseline effects, which are shown in Fig. 1 . In sham 22 and aortic blood velocity were shifted downward, while rats, at doses .10 mg / kg of isoproterenol, L-NAME dose-response curves for SVR and t were shifted upward potentiated the isoproterenol mediated increases in LV (Fig. 2) . In both groups of rats, isoproterenol administradP/dt and aortic blood velocity and potentiated the isotion did not change LV dP/dt, aortic blood velocity, SVR, proterenol-induced reduction in SVR and t in sham rats 28 or t at doses between 10 and 2 mg / kg, however, at (Fig. 2) . No such effects were found in MI rats. In 22 doses higher than 10 mg / kg, there were progressive contrast, L-NAME did not alter the isoproterenol stimudecreases in SVR, t, and aortic blood velocity, while LV lated MAP or LV end diastolic pressure in either sham or dP/dt was progressively increased.
MI rats (data not shown). In addition, no effects of L- NAME were found on the isoproterenol stimulated HR velocity, t, and LV dP/dt, which means that the effects of responses in either group of rats (Fig. 2) . In sham rats, isoproterenol on these parameters is dependent on the interaction between isoproterenol-mediated response and presence of L-NAME, i.e., there is coupling between b-AR L-NAME is significant (P,0.05) for SVR, aortic blood and NO pathways. However, this interaction is significant Table 2 Effects of L-NAME and AG on pulsatile hemodynamics in sham and MI rats Values are mean6S.D. Z , Z , Z , impedance modulus at the 1st and 2nd harmonics, respectively. F, is phase shift; SV, stroke volume (cm / s); P , P , P , only for SVR in MI rats. AG (75 mg / kg) had no effect on greater decrease in cardiac output (aortic flow velocity), isoproterenol dose-responses in either group of rats (data relative to vasoconstriction, in MI rats. While the former not shown). mechanism could only be proven by direct measurement of peripheral arteriolar vasomotion in response to L-NAME, 3.7. Effects of L-NAME and AG on pulsatile the latter mechanism is the plausible result of greater hemodynamics afterload sensitivity in the setting of LV dysfunction. A decrease in cardiac output due to any direct influence of In sham rats, L-NAME increased (P,0.05) the impe-NO inhibition is not likely, since most investigators dance moduli Z and Z , the characteristic impedance Z , believe NO has a negative contractile effect. By similar 1 2 0 and the phase shifts F and F (Table 2 ). In contrast, reasoning, the decrease in LV dP/ dt is probably the result 1 2 stroke volume, pulsatile and total ventricular power were of increased LV afterload rather than due to decreased decreased (P,0.05) with L-NAME. However, AG incardiac contractility. creased (P,0.05) the impedance moduli Z and Z , the In contrast to the effects of L-NAME, AG did not affect 1 2 characteristic impedance Z , and decreased (P,0.05) steady-state hemodynamics in sham rats. This suggests that 0 stroke volume and total ventricular power. In MI rats, the iNOS does not significantly regulate normal cardiovascular only changes due to L-NAME were increases (P,0.05) in function. However, in MI rats, LV dP/dt was increased, in Z and F , and a decrease (P,0.05) in LV power. AG the absence of any effects of AG on SVR or LV EDP (LV 1 2 administration did not affect any of the pulsatile hemopre-load). Thus, it is possible that LV dP/dt increased after dynamic parameters in MI rats.
AG because the potentially positive contractile effects of iNOS inhibition were unopposed by any peripheral vasoconstrictive effects. Since AG did not increase either 4. Discussion MAP or SVR, we concluded that iNOS inhibition had no effect in the resistance vessels. Further, since LV dP/dt is The current study examines the hemodynamic effects of afterload-dependent and this afterload did not change with NOS inhibition in intact animals after MI. The study AG and since NO is known to depress cardiac contractility, design allowed the separation of the effects of basal and the increase in LV dP/dt with AG may imply a role for b-AR-stimulated NO release on pulsatile and steady-state iNOS in the heart. arterial function. Our major findings are that, in this compensated model of ischemic heart failure, (1) circulat-4.2. Effects of NO inhibition on in vivo pulsatile ory and cardiac responses to inhibition of NO by L-NAME hemodynamics suggest that eNOS, but not iNOS, is the principal regulator of integrated arterial hemodynamic function in rats. (2) While resistance arteries modulate steady-state hemoBoth basal and b-AR-stimulated NO regulation of hemodynamics, large arteries primarily determine pulsatile dynamic are attenuated after MI. (3) The attenuation of hemodynamics (aortic input and characteristic impedance). arterial hemodynamic effects after isoproterenol is meThe findings that basal aortic input impedance and phase diated, in part, by alterations in the b-AR-activation of shift are increased, and that ventricular power is decreased eNOS system after MI.
in rats after MI are in agreement with a previous study from our laboratory [10] . Aortic input impedance is a 4.1. Effects of NO inhibition on in vivo steady-state function of loading and arterial radius, while the charachemodynamics teristic impedance is proportional to aortic stiffness [18] . Therefore, while the increases in impedance moduli and L-NAME had a hypertensive effect in sham rats, with no the decrease in stroke volume with L-NAME is explained measurable effect in MI rats. Previous work suggests that by the vasoconstrictive effects of NO inhibition, the the increase in arterial blood pressure in sham rats probaincrease in characteristic impedance in sham rats with bly results from blocking the vasodilatory action of NO, L-NAME is the first demonstration that NO also modulates rather than from any direct effect of NOS inhibition on the vascular stiffness. This effect is associated with decreased sympathetic nervous system [14] [15] [16] [17] . In contrast to the ventricular power. In contrast, L-NAME does not further effect of L-NAME in sham rats, NOS inhibition had increase either aortic input or characteristic impedance negligible effects on arterial pressure in rats after MI.
after MI. This lack of response to NOS inhibition after MI Since arterial blood pressure is the product of cardiac is probably explained by the well established observation output and SVR, the lack of effect on blood pressure was that endothelial-dependent NO release is diminished after the result of opposite but balanced effects of L-NAME on MI [4] . these two variables in MI rats.
Despite the absence of effects of iNOS inhibition on The differential effect of NOS inhibition via L-NAME peripheral resistance, it increased aortic input impedance on arterial pressure in sham versus MI is the result of and decreased stroke volume in sham rats to the same either more intense vasoconstriction in sham rats, or a degree as non-specific NOS inhibition with L-NAME.
These data suggest, therefore, that iNOS controls vasomowhile eNOS is the primary NOS regulator of peripheral tion in large, but not resistance, vessels in sham rats.
resistance vessels. The control of arterial hemodynamics However, the lack of effect of AG on pulsatile hemoby NOS is markedly attenuated in MI rats. In addition, we dynamics in MI rats suggests that iNOS may be downregupresent evidence that endothelial dysfunction is mediated lated in the large arteries in the setting of heart failure.
by alterations in the NOS system and contributes to b-AR Combined with the observations on steady-state hemohypo-responsiveness in heart failure due to MI. dynamics, these data suggest that the iNOS isoform plays a major role in modulating vasomotion in large conduit arteries while eNOS controls primarily resistance vessels
